HIGHLIGHTS
- who: Report and collaborators from the Internal Medicine, Doctors Hospital at Renaissance/University of Texas Rio Grande Valley, Edinburg, USA , have published the research: Review began 10/28/2022 Review ended 11/04/2022 Published 11/05/2022 u00a9 Copyright, in the Journal: (JOURNAL) of November/05,/2022
- what: As of this date, there are no reports of documented cases of casirivimab/imdevimab infusion-induced myocarditis.
SUMMARY
Myopericarditis as a complication of monoclonal antibody infusion or as a complication of a hypersensitivity reaction to antibody infusions (Kounis syndrome) might be an . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.